Earnings report for Milestone Pharmaceuticals Inc. (MIST) expected on March 19. Analysts predict 16 cents per share on $1.20M revenue.
Latest Ratings for MIST
DateFirmActionFromTo Mar 2021HC Wainwright & Co.Initiates Coverage OnBuy Jul 2020OppenheimerUpgradesPerformOutperform Jul 2020JefferiesUpgradesHoldBuy
Importance Rank:
1
